See full prescribing information for. ABILIFY MAINTENA. ABILIFY MAINTENA (aripiprazole) for extended-release injectable suspension, for intramuscular use.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ABILIFY MAINTENA safely and effectively. See full prescribing information for ABILIFY MAINTENA. ABILIFY MAINTENA (aripiprazole) for extended-release injectable suspension, for intramuscular use Initial U.S. Approval: 2024
adults, ABILIFY MAINTENA (aripiprazole). Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE, for ABILIFY MAINTENA.
Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE, for ABILIFY MAINTENA If you are currently prescribed ABILIFY MAINTENA
ABILIFY MAINTENA (aripiprazole). Is a once-monthly treatment for schizophrenia in adults. Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE, for ABILIFY MAINTENA.
INDICATIONS and IMPORTANT SAFETY INFORMATION for ABILIFY MAINTENA (aripiprazole). IMPORTANT SAFETY INFORMATION. INDICATIONS. ABILIFY MAINTENA (aripiprazole)
adults, ABILIFY MAINTENA (aripiprazole). Please read FULL PRESCRIBING INFORMATION, including BOXED WARNING, and MEDICATION GUIDE, for ABILIFY MAINTENA.
(Prescribing information: Abilify 2024, Abilify Maintena 2024, Abilify venlafaxine in treatment-resistant depression. Depress Anxiety
Abilify contains the active drug aripiprazole and belongs to the antipsychotics drug class. prescribing information for Abilify and Abilify Maintena. Your
Comments